• Latest Posts

Italian Gene Therapy Biotech aims high by Collaborating with US Giant Amgen

German Biotech wins FDA Approval for New Liver Cancer Trial

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

How a Breakthrough Leukemia Drug is Shaping the Future of Bispecific T-Cell Therapies

18,000 Patients Enrolled for One of the Most Comprehensive Trials Against Cholesterol

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

ADVERTISEMENT

Cinfa Biotech’s Biosimilar is on the Starting Block!

The First Ever Oncolytic Immunotherapy is Set to Reach the European Market

What Happened this Week? Human Embryos Back on the Bench, Stem Cells in your Heart and New Antibiotics

Replimune smashes Oncolytic viral €26.8M series A financing round

Roche’s patent halts an Amgen biosimilar debut

Forbion’s Dutch biotech draws Cali’s Amgen into €1.36Bn deal

ADVERTISEMENT